Asymmetry Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Asymmetry Capital Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-96,297	Closed	-$1.71M	–	38
2018 Q3	$1.71M	Sell	96,297 -6,862	-7%	-$118K	1.58%	30
2018 Q2	$1.42M	Buy	103,159 +11,724	+13%	+$139K	1.4%	27
2018 Q1	$831K	Buy	91,435 +9,951	+12%	+$54.9K	1.04%	32
2017 Q4	$349K	Buy	+81,484	New	+$388K	0.47%	29

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Asymmetry Capital Management's ECYT Position: Q4 2018 in Review

Asymmetry Capital Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 96,297 shares — an estimated $1.71M sold.

Asymmetry Capital Management first reported a position in ECYT in Q4 2017 and held it in 4 quarters. The position peaked at $1.71M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Asymmetry Capital Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Asymmetry Capital Management sold 96,297 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.71M.
Asymmetry Capital Management first reported a position in Endocyte, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
Asymmetry Capital Management's Endocyte, Inc. Common Stock position peaked at $1.71M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Asymmetry Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.